Pharmaceutical companies
Financial contributions by the United States government for scientific assistance of research and development of prescription drug among pharmaceutical firms would only mean that the drug should be affordable. Government contribution to social welfare implies that pharmaceutical should reciprocate with low prices.
Kang article examines the distribution of funds for pharmaceutical companies in the industrialized countries. The findings revealed that the United States had disproportionate funding for pharmaceutical companies, and only six out of ten were open to disclosing their financial transactions with the public. According to the reports, the government contributed over $ 88 million for research and other activities carried out by pharmaceutical companies (Book, 2018). The disparities existing reveal that it would be relatively difficult to realize a reduction in the price of prescription drugs in as much as there is government funding for pharmaceutical projects (Kang, 2019).
Walton’s article reveals that oncological research by pharmaceutical has resulted in the development of prescription drugs for treating medical conditions such as Hepatitis C, and lipid therapy. In as much as this translates to improved healthcare, the cost of these new therapies is relatively high for the average citizen. The trends also show a probability in the rise for future demand for healthcare, and this will translate to an increase in the general spending for the USA in the long run. There are concerns over the pricing and value of the drugs. The government hopes that financial incentives such as progressive taxes, and payments made through health initiative such as Medicaid coverage will help reduce the prices of drugs manufactured by pharmaceutical companies to allow for equitable distribution of these resources (Walton, 2017). Therefore, the US government hopes that its contribution to pharmaceutical companies in terms of legislation and finances would result in reduced prices for prescription drugs.
The Bible in Matthew 7: 12 encourages Christians to do top others what they would want them to do to you. Therefore, pharmaceutical companies should reciprocate government funding with lower costs for drugs.